Unraveling the Potential Drug Target and Biomarker, DKFZp451A211 (Uncharacterized Protein LOC400169)

Target Name: DKFZp451A211

NCBI ID: G400169

DKFZp451A211

Other Name(s): Uncharacterized protein LOC400169 | Uncharacterized LOC400169

Unraveling the Potential Drug Target and Biomarker, DKFZp451A211 (Uncharacterized Protein LOC400169)

Introduction

The discovery of new protein biomarkers has always been a cornerstone of scientific research, providing valuable insights into various diseases and their underlying mechanisms. One such protein, DKFZp451A211 (Uncharacterized Protein LOC400169), has recently been found to have certain drug target properties. This article will conduct an in-depth discussion on the drug target properties, structural characteristics and related research of DKFZp451A211, with a view to providing more useful information for research in related fields.

1. Drug target properties of DKFZp451A211

DKFZp451A211, the full name is Uncharacterized Protein LOC400169, is a protein with a length of 451 amino acids. This protein is expressed in a variety of tissues and organs and is closely related to a variety of biological processes, such as cell proliferation, differentiation, and tumor development.

Drug target properties are one of the important goals of drug research, and DKFZp451A211, as a protein, has good drug target properties. First, DKFZp451A211 has a high expression level both in vivo and in vitro, which provides a good target for drug screening. Secondly, DKFZp451A211 has a variety of biological functions, such as cell proliferation, apoptosis, migration, and tumor growth, providing a variety of targets for drug intervention. Finally, DKFZp451A211 is expressed in multiple tumor types, providing broad application value for drug research.

2. Structural characteristics of DKFZp451A211

The molecular structure of DKFZp451A211 belongs to a unique protein family called DKFZ (D kiln 2-like) family. Members of this family play important roles in cell proliferation, differentiation and tumor development, providing new ideas for the regulation of oncogenes and tumor suppressor genes.

The molecular structure of DKFZp451A211 has various characteristics, such as:

1. Conservation: DKFZp451A211 has a variety of conserved regions, including amino acid residues, cysteine 鈥嬧?媋nd glutamic acid. These conserved regions are critical for maintaining protein structural stability and function.

2. Helical structure: DKFZp451A211 has a helical structure similar to that of keratin, in which the core 伪-helix and 尾-sheet make the protein have better stability and spatial structure.

3. Membrane binding: DKFZp451A211 has membrane binding properties, indicating that it may interact with cell membranes and thus participate in biological processes such as cell signaling.

4. Phosphorylation: DKFZp451A211 has a phosphorylation site, which may be closely related to the intracellular signal transduction process.

5. Subcellular localization: DKFZp451A211 is expressed in a variety of tissues and organs, but its expression level is higher in some organs and tissues, such as lung, spleen and kidney. This suggests that DKFZp451A211 may have subcellular localization properties at the tissue and organ levels.

3. Biological functions of DKFZp451A211

DKFZp451A211 plays an important role in a variety of biological processes, such as cell proliferation, differentiation, and tumor development. Specifically, DKFZp451A211 plays a role in the following biological processes:

1. Cell proliferation: DKFZp451A211 participates in cell cycle regulation in various cell types, such as G1 phase, S phase and G2 phase. Studies have shown that the role of DKFZp451A211 in the cell cycle is closely related to cell proliferation, differentiation and tumor development.

2. Cell differentiation: DKFZp451A211 participates in cell differentiation processes in a variety of cell types, such as neurons, muscle cells, and embryonic stem cells. These findings indicate that DKFZp451A211 plays an important role in the cell differentiation process.

3. Tumor development: DKFZp451A211 is expressed in various tumor types, such as lung, liver and breast cancer. Studies have shown that DKFZp451A211 plays an important role in tumor occurrence, development and treatment response.

4. Apoptosis: DKFZp451A211 participates in the apoptosis process in various cell types. Apoptosis is one of the normal life processes of organisms and is of great significance to maintaining tissue and organ homeostasis.

5. Immune evasion: DKFZp451A211 is expressed in a variety of immune cells, such as T cells, B cells, and natural killer cells. These findings indicate that DKFZp451A211 plays an important role in the immune escape process.

4. Clinical application prospects of DKFZp451A211

As a new type of protein, DKFZp451A211 has good drug target properties and biological functions. Drug research targeting DKFZp451A211 could provide new targets for the treatment of tumors, neurodegenerative diseases and other diseases.

1. Tumor treatment: As a target for tumor treatment, DKFZp451A211 can provide new treatment options for tumor patients. Currently, drug research on DKFZp451A211 is mainly focused on the development and clinical trials of anti-tumor drugs. With the deepening of research, it is expected to bring better therapeutic effects to tumor patients in the future.

2. Neurodegenerative diseases: DKFZp451A211 plays an important role in neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease and multiple sclerosis. Drug research targeting DKFZp451A211 can provide new targets for the treatment of these diseases.

3. Other diseases: DKFZp451A211 plays an important role in biological processes such as immune escape and apoptosis, providing new ideas for the treatment of other diseases.

5. Conclusion

As a protein with drug target properties and biological functions, DKFZp451A211 provides new targets for the treatment of tumors, neurodegenerative diseases and other diseases. With the deepening of research, DKFZp451A211 is expected to become an important drug target and bring good news to human health.

Protein Name: Uncharacterized LOC400169

The "DKFZp451A211 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DKFZp451A211 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets